Trusted by Industry Leaders at
If good science is about storytelling, our bioinformatic tools often take us in the complete opposite direction. We grasp at UMAP embeddings and heatmaps trying to find something significant, or we simply outsource the analysis to someone else. TerraFlow gives agency back to the scientist with a plain-English report anyone can pick up and instantly understand.
Analysis
Complete cellular profiling
Ever wonder what you’re missing in your data? Our exhaustive approach detects cell types routinely ignored by traditional methods, allowing scientists to extract new insights from the data they already have.
Annotation
Crystal clear phenotypes
TerraFlow defines each population with a simple gating path like GITR+PD1+ or CCR7+CD95+. It then uses ChatGPT-enabled technology (FlowGPT) to explain how each protein combination relates to your disease of interest.
Access
On demand answers
Upload data, label patient groups, and hit “Submit”. In 24 hours you’ll get back a complete immuno-phenotyping report. It’s that easy.
Chief Executive Officer, Talon Biomarkers
Still clustering your data?
You may be leaving your biggest breakthroughs on the table
See how TerraFlow compares to traditional methods like FlowSOM and UMAP
| UMAP | FlowSOM | TerraFlow | |
|---|---|---|---|
| Phenotypes evaluated | None | Tens | Tens of thousands |
| Cell annotation | Visual inspection | Cluster MFIs | Explicit gating strategies |
| Tuning | Tune multiple parameters | Anticipate number of clusters | No tuning necessary |
| Randomness | Different results every time | Different results every time | Same results every time |
| Use case | Visualize data | Identify major subtypes | Define disease-associated cell types |
Phenotypes evaluated
| UMAP | None |
| FlowSOM | Tens |
| TerraFlow | Tens of thousands |
Cell annotation
| UMAP | Visual inspection |
| FlowSOM | Cluster MFIs |
| TerraFlow | Explicit gating strategies |
Tuning
| UMAP | Tune multiple parameters |
| FlowSOM | Anticipate number of clusters |
| TerraFlow | No tuning necessary |
Randomness
| UMAP | Different results every time |
| FlowSOM | Different results every time |
| TerraFlow | Same results every time |
Use case
| UMAP | Visualize data |
| FlowSOM | Identify major subtypes |
| TerraFlow | Define disease-associated cell types |
Our Promise
TerraFlow is the first platform built for disease immunophenotyping. If there’s a disease signature in your data, our platform will find it and deliver clear, replicable, disease-specific phenotypes every time.
Dan Freeman
Chief Executive Officer, TerraFlow
